Header Logo

Connection

NAVEEN PEMMARAJU to Proteomics

Back to Details
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Proteomics.
NAVEEN PEMMARAJU
Connection Strength
0.034
Proteomics
  1. A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood Cancer J. 2023 06 29; 13(1):101.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.